Discover how AGO2 protein plays a critical role in multiple myeloma cell growth and IMiD drug effectiveness in this groundbreaking cancer research.
Exploring why CRBN and DDB1 mutations are absent in myeloma despite IMiD resistance, and its clinical significance for cancer treatment.